Portal Biotech
Generated by Meeveem AI
"Decoding proteins at the single molecule level to accelerate drug discovery and diagnostics"
London
•11 - 50 Employees
•Biotechnology
About Portal Biotech
Portal Biotech develops nanopore technology that sequences individual protein molecules in real time. Where traditional methods fragment proteins and lose information, Portal's platform reads entire proteins end to end, capturing mutations, modifications and isoforms that determine protein function. This single molecule precision reveals the complete proteome rather than averaged fragments. The technology matters because proteins execute biological processes, yet the field has lacked comprehensive analysis tools. Portal's bench-top instruments give researchers the ability to decode protein complexity rapidly and affordably, enabling better therapeutics, faster pandemic response and deeper biological understanding.
Illustrative visual - may not reflect the actual offering.
Illustrative visual - may not reflect the actual offering.
34
Team Members
2021
Founded
Series A
Funding
On-Site
Work Environment
Our Vision
A world where every protein variant is understood in full biological context, enabling precise medicine, rapid threat detection and fundamental breakthroughs in how we comprehend and intervene in living systems.
Our Mission
At Portal Biotech, our mission is to empower scientists to understand proteins in real time, enabling faster drug discovery, more accurate diagnostics and stronger pandemic readiness.